Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: First evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2687-2696

  Pagotto, U ^a   Marsicano, G ^a   Fezza, F ^b   Theodoropoulou, M ^a   Grubler Y ^a   Stalla, J ^a   Arzberger, T ^a   Milone, A ^b   Losa, M ^c   Di Marzo, V ^b   Lutz, B ^a   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b CNR   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CORTICOTROPIN; GROWTH HORMONE RELEASING FACTOR; RIMONABANT;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DRUG MECHANISM; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNTHESIS; TUMOR CELL;

ADENOMA; ADOLESCENT; ADULT; AGED; CANNABINOIDS; ENDOCANNABINOIDS; FEMALE; HORMONES; HUMANS; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 17844379461     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.6.2687     Document Type: Article

References (43)

1. The functional neuroanatomy of brain cannabinoid receptors
2. Behavioral effects of cannabinoid agents in animals
3. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion
4. Pharmacology of cannabinoid CB1 and CB2 receptors
5. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
6. Effects of Δ-9-tetrahydrocannabinol, cannabinol and cannabidioI, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat
7. Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats
8. Effects of carmabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs
9. The effect of 1-trans-Attetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats
10. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat
11. Hypothalamic action of A-9-tetrahydrocarmabinol to inhibit the release of prolactin and growth hormone in the rat
12. 9-Tetrahydrocannabinol suppression of prolactin secretion in the rat: Lack of direct pituitary effect
13. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland
14. Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland
15. Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland
16. The cytogenesis and pathogenesis of pituitary adenomas
17. Management of pituitary tumors
18. Molecular genetic studies of sporadic pituitary tumors
19. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth
20. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas
21. Finding of the endocannabinoid signalling system in Hydra, a very primitive orgarusm: Role in the feeding response
22. Growth hormone (GH)releasing peptide stimulation of GH release from human somatotroph adenoma cells: Interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide
23. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas
24. Octreotide exerts different effects in vivo and in vitro in Cushing's disease
25. Silent corticotropic adenomas of the human pituitary gland: A histologic, immunocytologic, and ultrastructural study
26. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by Δ-9-tetrahydrocannabinol
27. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
28. Peptidomimetic regulation of growth hormone secretion
29. Does the endogenous cannabinoid system play a role in the regulation of anterior pituitary hormone secretion? An in vitro study
30. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes
31. 2 receptor-mediated actions of anartdamide in mouse brain
32. Progress toward understanding the cannabinoid receptor and its second messenger systems
33. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: Evidence for agonist-specific trafficking of intracellular responses
34. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus palidus slices
35. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
36. 1-tetrahydrocannabinol in rats
37. Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat
38. 1 cells
39. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells
40. Regulation and role of intrapituitary IL-6 production by folliculostellate cells
41. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
42. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocarmabinoids leads to inhibition of human breast and prostate cancer cell proliferation
43. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation